Therapeutic area intelligence for Combination Analgesics with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

FDA →

Pharmobedient →

Recent signals(3)

RegulatoryJune 28, 2026

FDA Approval Update for Acetaminophen and Codeine Phosphate by Pharmobedient

The FDA has issued an approval letter for ANDA087006 concerning Acetaminophen and Codeine Phosphate.

StrategyJune 28, 2026

FDA Approves ANEXSIA 5/325 Submission by SPECGX LLC

The FDA has approved the ANDA submission for ANEXSIA 5/325, containing acetaminophen and hydrocodone bitartrate.

Regulatory

June 26, 2026

FDA Approval Status Update for Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate

The FDA has provided an approval status update for ANDA204209, a combination product containing acetaminophen, caffeine, and dihydrocodeine bitartrate.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.